rs118141823

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014844.5(TECPR2):​c.1802C>T​(p.Pro601Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0194 in 1,583,794 control chromosomes in the GnomAD database, including 353 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P601P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.016 ( 29 hom., cov: 32)
Exomes 𝑓: 0.020 ( 324 hom. )

Consequence

TECPR2
NM_014844.5 missense

Scores

2
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.0500

Publications

5 publications found
Variant links:
Genes affected
TECPR2 (HGNC:19957): (tectonin beta-propeller repeat containing 2) The protein encoded by this gene is a member of the tectonin beta-propeller repeat-containing (TECPR) family, and contains both TECPR and tryptophan-aspartic acid repeat (WD repeat) domains. This gene has been implicated in autophagy, as reduced expression levels of this gene have been associated with impaired autophagy. Recessive mutations in this gene have been associated with a hereditary form of spastic paraparesis (HSP). HSP is characterized by progressive spasticity and paralysis of the legs. There is also some evidence linking mutations in this gene with birdshot chorioretinopathy (BSCR), which results in inflammation of the choroid and retina. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
TECPR2 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 49
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002579838).
BP6
Variant 14-102434619-C-T is Benign according to our data. Variant chr14-102434619-C-T is described in ClinVar as Benign. ClinVar VariationId is 220729.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0165 (2506/152272) while in subpopulation AMR AF = 0.0281 (429/15294). AF 95% confidence interval is 0.0259. There are 29 homozygotes in GnomAd4. There are 1195 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 29 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014844.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TECPR2
NM_014844.5
MANE Select
c.1802C>Tp.Pro601Leu
missense
Exon 9 of 20NP_055659.2
TECPR2
NM_001172631.3
c.1802C>Tp.Pro601Leu
missense
Exon 9 of 17NP_001166102.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TECPR2
ENST00000359520.12
TSL:1 MANE Select
c.1802C>Tp.Pro601Leu
missense
Exon 9 of 20ENSP00000352510.7
TECPR2
ENST00000558678.1
TSL:1
c.1802C>Tp.Pro601Leu
missense
Exon 9 of 17ENSP00000453671.1
TECPR2
ENST00000856897.1
c.1802C>Tp.Pro601Leu
missense
Exon 9 of 20ENSP00000526956.1

Frequencies

GnomAD3 genomes
AF:
0.0165
AC:
2510
AN:
152154
Hom.:
29
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00393
Gnomad AMI
AF:
0.0559
Gnomad AMR
AF:
0.0281
Gnomad ASJ
AF:
0.0332
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00828
Gnomad FIN
AF:
0.0109
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0227
Gnomad OTH
AF:
0.0229
GnomAD2 exomes
AF:
0.0165
AC:
3847
AN:
233650
AF XY:
0.0165
show subpopulations
Gnomad AFR exome
AF:
0.00453
Gnomad AMR exome
AF:
0.0202
Gnomad ASJ exome
AF:
0.0298
Gnomad EAS exome
AF:
0.0000545
Gnomad FIN exome
AF:
0.0120
Gnomad NFE exome
AF:
0.0215
Gnomad OTH exome
AF:
0.0267
GnomAD4 exome
AF:
0.0197
AC:
28271
AN:
1431522
Hom.:
324
Cov.:
30
AF XY:
0.0194
AC XY:
13689
AN XY:
707384
show subpopulations
African (AFR)
AF:
0.00360
AC:
119
AN:
33052
American (AMR)
AF:
0.0208
AC:
900
AN:
43320
Ashkenazi Jewish (ASJ)
AF:
0.0324
AC:
780
AN:
24094
East Asian (EAS)
AF:
0.0000254
AC:
1
AN:
39294
South Asian (SAS)
AF:
0.00834
AC:
683
AN:
81868
European-Finnish (FIN)
AF:
0.0142
AC:
741
AN:
52308
Middle Eastern (MID)
AF:
0.00407
AC:
23
AN:
5650
European-Non Finnish (NFE)
AF:
0.0218
AC:
23868
AN:
1092864
Other (OTH)
AF:
0.0196
AC:
1156
AN:
59072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
1802
3604
5405
7207
9009
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
880
1760
2640
3520
4400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0165
AC:
2506
AN:
152272
Hom.:
29
Cov.:
32
AF XY:
0.0161
AC XY:
1195
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.00392
AC:
163
AN:
41554
American (AMR)
AF:
0.0281
AC:
429
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0332
AC:
115
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00787
AC:
38
AN:
4826
European-Finnish (FIN)
AF:
0.0109
AC:
116
AN:
10600
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0227
AC:
1545
AN:
68022
Other (OTH)
AF:
0.0222
AC:
47
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
125
250
375
500
625
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0199
Hom.:
138
Bravo
AF:
0.0174
TwinsUK
AF:
0.0175
AC:
65
ALSPAC
AF:
0.0257
AC:
99
ESP6500AA
AF:
0.00613
AC:
27
ESP6500EA
AF:
0.0229
AC:
197
ExAC
AF:
0.0165
AC:
2002
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hereditary spastic paraplegia (1)
-
-
1
Hereditary spastic paraplegia 49 (1)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
5.5
DANN
Benign
0.96
DEOGEN2
Benign
0.013
T
Eigen
Benign
-0.92
Eigen_PC
Benign
-0.94
FATHMM_MKL
Benign
0.018
N
LIST_S2
Benign
0.65
T
MetaRNN
Benign
0.0026
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.0
L
PhyloP100
0.050
PrimateAI
Benign
0.22
T
PROVEAN
Uncertain
-2.8
D
REVEL
Benign
0.046
Sift
Uncertain
0.021
D
Sift4G
Benign
0.49
T
Polyphen
0.0040
B
Vest4
0.022
MPC
0.31
ClinPred
0.0062
T
GERP RS
-0.26
Varity_R
0.032
gMVP
0.20
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs118141823; hg19: chr14-102900956; API